Therapy development inspired by patients


Find the latest press releases and communications on our news section.

Treeway Licensing Deal with Specialised Therapeutics

Singapore, August 28th, 2023 –Independent biopharmaceutical company Specialised Therapeutics Asia Pte Ltd (ST) will partner with Netherlands based biotechnology company Treeway BV to commercialise a new therapy to treat Amyotrophic Lateral Sclerosis (ALS)¹ – the most common form of Motor Neurone...

read more

Treeway announces first patient enrolled in the Phase 2a ASURE clinical trial exploring the safety and effectiveness of oral edaravone to delay disease progression in Alzheimer’s patients

Tilburg, March 6, 2023 – Treeway, in collaboration with the Alzheimer Drug Discovery Foundation (ADDF), announces today the successful enrollment of the first patient in the Alzheimer’s Disease Study Using Oral Edaravone (ASURE), Phase 2a clinical trial. The trial will include 60 patients in...

read more

Spotlight: Miranda de Jager

Meet Miranda de Jager, Treeway’s CMC consultant. She joined the company in 2017 as a chemistry, manufacturing and controls consultant.   Miranda de Jager joined with plenty of experience and immense motivation and commitment to the cause of developing treatment for ALS. Throughout her career, the...

read more